These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34493471)

  • 1. Comment on "Autofluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw (MRONJ): a retrospective single-center study" by Otto et al. (May 2021).
    Desai RS; Bansal SP; Shirsat PM; Dhanawade SS; Chavhan SU
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jan; 133(1):118-119. PubMed ID: 34493471
    [No Abstract]   [Full Text] [Related]  

  • 2. Autofluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw (MRONJ): a retrospective single-center study.
    Otto S; Schnödt EM; Haidari S; Brunner TF; Aljohani S; Mosleh M; Ristow O; Troeltzsch M; Pautke C; Ehrenfeld M; Fliefel R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 May; 131(5):519-526. PubMed ID: 33309263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study.
    Otto S; Ristow O; Pache C; Troeltzsch M; Fliefel R; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2016 Aug; 44(8):1073-80. PubMed ID: 27263757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
    Ristow O; Rückschloß T; Müller M; Berger M; Kargus S; Pautke C; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of auto-fluorescence and tetracycline fluorescence for guided bone surgery of medication-related osteonecrosis of the jaw: a randomized controlled feasibility study.
    Ristow O; Otto S; Geiß C; Kehl V; Berger M; Troeltzsch M; Koerdt S; Hohlweg-Majert B; Freudlsperger C; Pautke C
    Int J Oral Maxillofac Surg; 2017 Feb; 46(2):157-166. PubMed ID: 27856150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ).
    Ristow O; Otto S; Troeltzsch M; Hohlweg-Majert B; Pautke C
    J Craniomaxillofac Surg; 2015 Mar; 43(2):290-3. PubMed ID: 25541255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Autofluorescence Guide Surgeons in the Treatment of Medication-Related Osteonecrosis of the Jaw? A Prospective Feasibility Study.
    Giudice A; Bennardo F; Barone S; Antonelli A; Figliuzzi MM; Fortunato L
    J Oral Maxillofac Surg; 2018 May; 76(5):982-995. PubMed ID: 29175416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series.
    Aljohani S; Troeltzsch M; Hafner S; Kaeppler G; Mast G; Otto S
    Oral Dis; 2019 Mar; 25(2):497-507. PubMed ID: 30325561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication-related osteonecrosis of the mandible: an unusual presentation and treatment.
    Rothweiler R; Voss PJ; Schmelzeisen R; Metzger MC
    Int J Oral Maxillofac Surg; 2021 Apr; 50(4):511-515. PubMed ID: 32847710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
    Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
    J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New method of alloplastic reconstruction of the mandible after subtotal mandibulectomy for medication-related osteonecrosis of the jaw.
    Bräuer C; Lauer G; Leonhardt H
    Br J Oral Maxillofac Surg; 2018 Jul; 56(6):549-550. PubMed ID: 29751943
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Differences in Autofluorescence Between Viable and Nonvital Bone: A Case Report With Histopathologic Evaluation Performed on Medication-Related Osteonecrosis of the Jaws.
    Giovannacci I; Meleti M; Corradi D; Vescovi P
    J Oral Maxillofac Surg; 2017 Jun; 75(6):1216-1222. PubMed ID: 28061356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-layer closure techniques after bone surgery of medication-related osteonecrosis of the jaw - A single center cohort study.
    Ristow O; Rückschloß T; Bodem J; Berger M; Bodem E; Kargus S; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2018 May; 46(5):815-824. PubMed ID: 29631942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
    Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study.
    Hallmer F; Andersson G; Götrick B; Warfvinge G; Anderud J; Bjørnland T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Dec; 126(6):477-485. PubMed ID: 30249535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of segmental mandibular resection without microvascular reconstruction in patients affected by medication-related osteonecrosis of the jaw: a systematic review.
    Sacco R; Umar G; Guerra RC; Akintola O
    Br J Oral Maxillofac Surg; 2021 Jul; 59(6):648-660. PubMed ID: 34023155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution.
    Lopes RN; Rabelo GD; Rocha AC; Carvalho PA; Alves FA
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1288-95. PubMed ID: 25871903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of stage 2 medication-related osteonecrosis of the jaw compared to osteomyelitis.
    Kang SH; Won YJ; Kim MK
    Cranio; 2018 Nov; 36(6):373-380. PubMed ID: 28854059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
    Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
    Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.